Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06355765
Status:
COMPLETED
Last Update Posted:
2024-04-17
First Post:
2024-04-04
Brief Title:
Citicoline Antioxidants in Glaucoma
Sponsor:
University of Naples
Organization:
University of Naples
Study Overview
Official Title:
Effect of Oral Citicoline Vitamins A B C and E and Blackcurrant in Primary Open-Angle Glaucoma With OCT and Angiography
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the long-term effects of oral citicoline vitamins A B C and E and blackcurrant therapy in patients with primary open-angle glaucoma POAG using optical coherence tomography OCT OCT angiography OCTA and microperimetry parameters
Detailed Description:
AIMS To evaluate the long-term effects of oral citicoline vitamins A B C and E and blackcurrant therapy in patients with primary open-angle glaucoma POAG using optical coherence tomography OCT OCT angiography OCTA and microperimetry parameters
METHODS Fifteen patients with POAG treated group received one soluble liquid sachet daily for 20 days a month of a complementary dietary supplement containing in fixed combination citicoline vitamins A B C and E and blackcurrant for 1 year Fifteen age-matched subjects affected by POAG were given a placebo and served as a control group The patients underwent best corrected visual acuity BCVA Goldmann applanation tonometry microperimetry examination OCT and OCTA at the beginning of the study and then at 1 6 and 12 months
METHODS Fifteen patients with POAG treated group received one soluble liquid sachet daily for 20 days a month of a complementary dietary supplement containing in fixed combination citicoline vitamins A B C and E and blackcurrant for 1 year Fifteen age-matched subjects affected by POAG were given a placebo and served as a control group The patients underwent best corrected visual acuity BCVA Goldmann applanation tonometry microperimetry examination OCT and OCTA at the beginning of the study and then at 1 6 and 12 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None